Browsing Tag
Rhapsido
2 posts
Novartis strengthens oral BTK franchise as Rhapsido expands beyond chronic spontaneous urticaria
Novartis expands Rhapsido into symptomatic dermographism as early sales grow and remibrutinib advances across MS and immune diseases.
Novartis gains another potential MS growth engine after remibrutinib beats teriflunomide in two Phase III trials
Novartis shares surge after remibrutinib wins two Phase III MS trials, opening another potential growth opportunity alongside Kesimpta.